Physician
Chowdhry, Ishtiaq
Chowdhry, Ishtiaq was paid $413.72 by Medicaid between Jan 2018 and Dec 2018, across 19 billing codes. Its largest line is 99392, Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) — 50% of everything it billed.
33Billing provider infoCHOWDHRY, ISHTIAQ
HENDERSON, NV 89052
HENDERSON, NV 89052
33aNPI1467423822assigned 02/01/2006
33bProvider typePediatrics Physician
28Total paid$413.72
24GClaims2,155
24DCodes billed19
24AFirst – last monthJan 2018 – Dec 2018
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#254 of 267
Median peer was paid$116K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,155 | $413.72 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 50% | 144 | 143 | $208.82 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 32% | 187 | 179 | $133.32 |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 744 | 706 | $71.58 |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 0% | 55 | 52 | $0.00 |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 48 | 45 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 69 | 65 | $0.00 |
| 94760 | 0% | 83 | 73 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 68 | 64 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 0% | 105 | 101 | $0.00 |
| 90651 | 0% | 16 | 16 | $0.00 | |
| 90686 | 0% | 85 | 84 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 13 | 13 | $0.00 |
7 more codes
| 94664 | 0% | 49 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 43 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 144 | $0.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 206 | $0.00 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 0% | 70 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 13 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.